The Gastric Antisecretory Drug market size is expected to reach $20.7 billion in 2030 at a CAGR of 5.8%, driven by increasing gastrointestinal disorders.
Read More
The global Ganciclovir market size is expected to reach $2.47 billion in 2030 at a CAGR of 12.4%, driven by rising CMV infection incidences.
Read More
The Gamma Delta T Cell Cancer Therapy market size is expected to reach $4.94 billion in 2030 at a CAGR of 18.4%, driven by growing clinical trials.
Read More
The Galantamine Hydrobromide market size is expected to reach $1.16 billion in 2030 at a CAGR of 9.6%, driven by rising Alzheimer’s prevalence.
Read More
The Gabapentin market size is expected to reach $4.45 billion in 2030 at a CAGR of 8.1%, driven by rising epilepsy prevalence.
Read More
The G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design market size is expected to reach $4.89 billion in 2030 at a CAGR of 13.0%, driven by demand for precision medicine.
Read More
The Functional Supplements market size is expected to reach $104.42 billion in 2030 at a CAGR of 9.4%, driven by growing health and wellness awareness.
Read More
The Functional Dyspepsia Drug market size is expected to reach $12.24 billion in 2030 at a CAGR of 6.2%, driven by rising metabolic disorder prevalence.
Read More
The Fulvestrant Injection market size is expected to reach $1.97 billion in 2030 at a CAGR of 8.0%, driven by rising breast cancer prevalence.
Read More
The Fuchs Endothelial Corneal Dystrophy market size is expected to reach $271.04 billion in 2030 at a CAGR of 7.8%, driven by growing corneal transplant demand.
Read More